Better Biotech Stock: CRISPR Therapeutics or Twist Bioscience?

CRISPR Therapeutics (NASDAQ: CRSP) focuses on modifying DNA. Twist Bioscience (NASDAQ: TWST) focuses on making DNA. Both companies' technologies appear to have tremendous potential. But which is the better biotech stock to buy? That's the question that Motley Fool contributors Keith Speights and Brian Orelli address in this Motley Fool Live video recorded on Jan. 19. 

Continue reading

Source Fool.com